On episode 25 of PSQH: The Podcast, Oliver Schacht, CEO of OpGen, talks about COVID-19 and antibiotic resistance.
Oliver Schacht, a corporate finance professional and expert in the molecular diagnostics industry, is the CEO of OpGen, a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease. Schacht obtained his Diploma in European Business Administration at the European School of Business in Reutlingen and London in 1994 as well as a Master’s degree and a PhD at the University of Cambridge (UK). The interview was recorded in December.
Listen to the episode below.